Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation

 Abstract

Smyd3 is a lysine methyltransferase implicated in chromatin and cancer regulation. Here we show that Smyd3 catalyzes histone H4 methylation at lysine 5 (H4K5me). This novel histone methylation mark is detected in diverse cell types and its formation is attenuated by depletion of Smyd3 protein. Further, Smyd3-driven cancer cell phenotypes require its enzymatic activity. Thus, Smyd3, via H4K5 methylation, provides a potential new link between chromatin dynamics and neoplastic disease.

Full Text Options
Article
Metrics
 Share
 Supplemental Material
 Info
Pages
340 - 343
doi
10.4161/epi.19506
Type
Brief Report
 Metrics
 Cite This Article
 Permissions
Creative Commons License Permissions
 Reprints
Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation